Viking Global Investors LP Bio N Tech Se Transaction History
Viking Global Investors LP
- $29.6 Billion
- Q4 2024
A detailed history of Viking Global Investors LP transactions in Bio N Tech Se stock. As of the latest transaction made, Viking Global Investors LP holds 940,850 shares of BNTX stock, worth $113 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
940,850
Previous 46,294
1932.34%
Holding current value
$113 Million
Previous $5.5 Million
1849.96%
% of portfolio
0.36%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$987 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$529 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$516 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...